Yan Xi, Niu Yinghao, Yang Xingxiao, Zhao Riyang, Cui Wenxuan, Guo Xiujuan, Zhang Jinyan, Ma Ming
Department of Clinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Department of Clinical Biobank, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Sci Rep. 2025 Mar 19;15(1):9462. doi: 10.1038/s41598-025-93056-8.
Objective This study aimed to identify laboratory indicators with significant implications for bone marrow invasion in gastric cancer patients and to evaluate their prognostic value. Methods A retrospective analysis of the clinical data of 320 gastric cancer patients who underwent either bone marrow cytological examination or bone marrow biopsy at our hospital between January 2013 and December 2023 was conducted. Among these patients, 31 patients with confirmed bone marrow invasion composed the study group, whereas 34 stage IV gastric cancer patients without bone marrow invasion composed the control group. Differences in demographic and laboratory data between the two groups were compared. Receiver operating characteristic curves were used to identify valuable indicators for predicting bone marrow invasion in patients with gastric cancer. Survival analysis was performed using the Kaplan‒Meier method and included the plotting of survival curves. Additionally, Cox proportional hazards regression analysis was performed to evaluate independent prognostic factors. Results Significantly different values (all P < 0.05) were observed for age, peripheral blood immature cells, Hb, PLT, SII, FIB, PT, FDP, D-Dimer, FDP/FIB, CEA, and CA72-4 between stage IV gastric cancer patients with and without bone marrow infiltration. The ROC analysis indicated that at a threshold value of 5.197 for FDP/FIB, the AUC was 0.958 (P < 0.01). Within the cohort of 65 stage IV gastric cancer patients, those with bone marrow invasion and high FDP/FIB ratios exhibited notably shorter median survival times than those without bone marrow invasion and with low FDP/FIB ratios (χ2 = 25.928, 20.128, P < 0.001). Multivariate analysis demonstrated that bone marrow invasion (HR = 4.148, P = 0.020) and the FDP/FIB ratio (HR = 1.026, P = 0.024) were independent risk factors influencing the prognosis and survival outcome of stage IV gastric cancer patients. Among the subset of 31 gastric cancer patients with bone marrow invasion, the median survival time for the high FDP/FIB group was 22 days, which was significantly shorter than the 60 days observed in the low FDP/FIB group (χ2 = 8.479, P = 0.004). Conclusion The FDP/FIB ratio can serve as an important indicator for the diagnosis and prognostic evaluation of bone marrow invasion in patients with gastric cancer.
目的 本研究旨在确定对胃癌患者骨髓侵犯具有重要意义的实验室指标,并评估其预后价值。方法 对2013年1月至2023年12月期间在我院接受骨髓细胞学检查或骨髓活检的320例胃癌患者的临床资料进行回顾性分析。其中,31例确诊为骨髓侵犯的患者组成研究组,34例无骨髓侵犯的IV期胃癌患者组成对照组。比较两组患者的人口统计学和实验室数据差异。采用受试者工作特征曲线确定预测胃癌患者骨髓侵犯的有价值指标。使用Kaplan-Meier方法进行生存分析并绘制生存曲线。此外,进行Cox比例风险回归分析以评估独立预后因素。结果 IV期有骨髓浸润和无骨髓浸润的胃癌患者在年龄、外周血未成熟细胞、血红蛋白(Hb)、血小板(PLT)、全身炎症反应指数(SII)、纤维蛋白原(FIB)、凝血酶原时间(PT)、纤维蛋白降解产物(FDP)、D-二聚体、FDP/FIB、癌胚抗原(CEA)和糖类抗原72-4方面观察到显著不同的值(所有P < 0.05)。ROC分析表明,FDP/FIB阈值为5.197时,曲线下面积(AUC)为0.958(P < 0.01)。在65例IV期胃癌患者队列中,骨髓侵犯且FDP/FIB比值高的患者的中位生存时间明显短于无骨髓侵犯且FDP/FIB比值低的患者(χ2 = 25.928,20.128,P < 0.001)。多因素分析表明,骨髓侵犯(风险比[HR] = 4.148,P = 0.020)和FDP/FIB比值(HR = 1.026,P = 0.024)是影响IV期胃癌患者预后和生存结局的独立危险因素。在31例有骨髓侵犯的胃癌患者子集中,FDP/FIB高分组的中位生存时间为22天,明显短于FDP/FIB低分组的60天(χ2 = 8.479,P = 0.004)。结论 FDP/FIB比值可作为胃癌患者骨髓侵犯诊断和预后评估的重要指标。